作者
Yile Wu,Xiaoqian Hu,Dequan Wu,Ruo-Jie Li,Xue‐Ping Wang,Jin Zhang,Zhou Liu,Weiwei Chu,Xi Zhu,Wenhui Zhang,Xue Zhao,Zhiyue Guan,Yunlan Jiang,Jinfeng Wu,Zhaohui Cui,Ju Zhang,Jia Li,Ru-Mei Wang,Shihua Shen,Chao-Yang Cai,Hai-Bin Zhu,Quan Jiang,Jing Zhang,Jia-Lan Niu,Xianpeng Xiong,Zhen Tian,Jianshe Zhang,Junlin Zhang,Liling Tang,A J Liu,Chengxiang Wang,Ming-Zhu Ni,Jing-Jing Jiang,Xiyao Yang,Min Yang,Qiang Zhou
摘要
This study aimed to investigate the prevalence and risk factors for carbapenem-resistant Enterobacterales colonisation/infection at admission and acquisition among patients admitted to the intensive care unit.A prospective and multicentre study.This study was conducted in 24 intensive care units in Anhui, China.Demographic and clinical data were collected, and rectal carbapenem-resistant Enterobacterales colonisation was detected by active screening. Multivariate logistic regression models were used to analyse factors associated with colonisation/infection with carbapenem-resistant Enterobacterales at admission and acquisition during the intensive care unit stay.There were 1133 intensive care unit patients included in this study. In total, 5.9% of patients with carbapenem-resistant Enterobacterales colonisation/infection at admission, and of which 56.7% were colonisations. Besides, 8.5% of patients acquired carbapenem-resistant Enterobacterales colonisation/infection during the intensive care stay, and of which 67.6% were colonisations. At admission, transfer from another hospital, admission to an intensive care unit within one year, colonisation/infection/epidemiological link with carbapenem-resistant Enterobacterales within one year, and exposure to any antibiotics within three months were risk factors for colonisation/infection with carbapenem-resistant Enterobacterales. During the intensive care stay, renal disease, an epidemiological link with carbapenem-resistant Enterobacterales, exposure to carbapenems and beta-lactams/beta-lactamase inhibitors, and intensive care stay of three weeks or longer were associated with acquisition.The prevalence of colonisation/infection with carbapenem-resistant Enterobacterales in intensive care units is of great concern and should be monitored systematically. Particularly for the 8.5% prevalence of carbapenem-resistant Enterobacterales acquisition during the intensive care stay needs enhanced infection prevention and control measures in these setting. Surveillance of colonisation/infection with carbapenem-resistant Enterobacterales at admission and during the patient's stay represents an early identification tool to prevent further transmission of carbapenem-resistant Enterobacterales.Carbapenem-resistant Enterobacterales colonization screening at admission and during the patient's stay is an important tool to control carbapenem-resistant Enterobacterales spread in intensive care units.